JLE

Hépato-Gastro & Oncologie Digestive

MENU

Metastatic colorectal cancer in the elderly: where are we? Volume 30, issue 7, September 2023

Figures


  • Figure 1

  • Figure 2
Authors
1 CHU de Caen, Service d’hépato-gastroentérologie, Avenue de la Côte de Nacre, CS 30001, 14033 Caen cedex 9
2 CHU Pontchaillou, Service des maladies de l’appareil digestif, 2 rue Henri Le Guilloux, 35033, Rennes Cedex 09
* Correspondance : A. Lièvre

Colorectal cancer is one of the most frequently diagnosed cancers in France and worldwide, with a peak incidence in patients over 70 years old, whose life expectancy is increasing. Long excluded from therapeutic trials, elderly patients are now the focus of special attention and dedicated studies. However, as treatment algorithms for metastatic colorectal cancer become increasingly complex, it is clear that a significant percentage of elderly colorectal cancer patients may not be optimally treated. The aim of this article is to review what is known about the treatment of metastatic colorectal cancer in the elderly and to discuss recent and ongoing advances.